Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 16 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

No open-market trades on record; showing all filings.

DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
Jan. 28, 2026 CREX A 13,794 · · 63,735 Direct +27.62% Acquired (price as of 2026-10-05)
April 1, 2025 CREX A 12,245 · · 43,142 Direct +39.63% Acquired (price as of 2026-10-05)
April 1, 2025 CREX A 6,799 · · 49,941 Direct +15.76% Acquired (price as of 2026-10-05)
Jan. 3, 2023 CREX A 38,710 · · 92,691 Direct +71.71% Acquired (price as of 2026-10-05)
Nov. 17, 2021 CREX A 60,000 · · 60,000 Direct · Acquired (price as of 2026-10-05)
Nov. 17, 2021 CREX A 10,860 · · 53,981 Direct +25.18% Acquired (price as of 2026-10-05)
Oct. 25, 2021 CREX A 4,630 · · 43,121 Direct +12.03% Acquired (price as of 2026-10-05)
July 1, 2021 CREX A 2,881 · · 38,491 Direct +8.09% Acquired (price as of 2026-10-05)
April 1, 2021 CREX A 3,416 · · 35,610 Direct +10.61% Acquired (price as of 2026-10-05)
Jan. 1, 2021 CREX A 4,845 · · 32,194 Direct +17.72% Acquired (price as of 2026-10-05)
Oct. 1, 2020 CREX A 6,388 · · 27,349 Direct +30.48% Acquired (price as of 2026-10-05)
July 7, 2020 CREX A 2,511 · · 20,961 Direct +13.61% Acquired (price as of 2026-10-05)
April 17, 2020 CREX A 8,013 · · 18,450 Direct +76.77% Acquired (price as of 2026-10-05)
Jan. 8, 2020 CREX A 4,085 · · 10,437 Direct +64.31% Acquired (price as of 2026-10-05)
Oct. 1, 2019 CREX A 3,634 · · 6,352 Direct +133.70% Acquired (price as of 2026-10-05)
July 1, 2019 CREX A 2,718 · · 2,718 Direct · Acquired (price as of 2026-10-05)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
Nov. 17, 2021 CREX Stock Options (right to buy) Common Stock (60,000) $2.21 Nov. 17, 2031 60,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).